Rasmus Irming Jølck
Corporate Officer/Principal presso Nanovi Radiotherapy A/S
Posizioni attive di Rasmus Irming Jølck
Società | Posizione | Inizio | Fine |
---|---|---|---|
Nanovi Radiotherapy A/S
Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Corporate Officer/Principal | - | - |
Storia della carriera di Rasmus Irming Jølck
Precedenti posizioni note di Rasmus Irming Jølck
Società | Posizione | Inizio | Fine |
---|---|---|---|
Technical University of Denmark | Corporate Officer/Principal | - | 03/11/2014 |
Statistiche
Distribuzione geografica
Danimarca | 3 |
Posizioni
Corporate Officer/Principal | 2 |
Settori
Health Technology | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Nanovi Radiotherapy A/S
Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Rasmus Irming Jølck
- Esperienza